Clinical Roundup MammaPrint test demonstrates utility in predicting chemotherapy benefit over five years December 13, 2024Vol.50 No.46
Clinical Roundup Genetic disposition increases the risk of breast cancer metastasis December 13, 2024Vol.50 No.46
Clinical Roundup Kisqali shows reduction in distant recurrence in early breast cancer, phase III data show December 13, 2024Vol.50 No.46
Clinical Roundup Darzalex Faspro-based regimens demonstrate improved rates of MRD negativity and PFS December 13, 2024Vol.50 No.46
Clinical Roundup Nektar Therapeutics announces NKTR-255 enhanced complete response rates in r/r LBCL December 13, 2024Vol.50 No.46
Clinical Roundup Calquence + Venetoclax shows superior PFS in untreated CLL in AMPLIFY phase III trial December 13, 2024Vol.50 No.46
Clinical Roundup Antibody shows encouraging results for treating high-risk follicular lymphoma and marginal zone lymphoma December 13, 2024Vol.50 No.46
